Biocytogen/Eucure Biopharma Announce the Completion of First Patient Dosing for ... - PR Newswire

Retrieved on: 2021-12-11 01:45:19

Tags for this article:

Click the tags to see associated articles and topics

Biocytogen/Eucure Biopharma Announce the Completion of First Patient Dosing for ... - PR Newswire. View article details on hiswai:

Excerpt

PRNewswire/ -- Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase II clinical trial of ...

Article found on: www.prnewswire.com